Aurion Biotech logo

Aurion Biotech

We're on a mission to cure blindness with our transformational platform of advanced therapies

94 employees · est. 2022 · Seattle, United States

VS
StemSight - Vision Unlimited logo

StemSight - Vision Unlimited

Curing blindness with regenerative cell therapies.

16 employees · est. 2021 · Tampere, Finland

StemSight - Vision Unlimited is the older company (2022 vs 2021); Aurion Biotech is the larger of the two.

Side-by-Side Comparison

Aurion Biotech StemSight - Vision Unlimited
Founded
2022 2021 older
Headquarters
Seattle, United States Tampere, Finland
Employees
94 larger 16
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Acquired Seed
Total Funding
$120.00M $2.80M
Funding Rounds
2 2
Services
Development of cell therapy treatments, Clinical trial execution, Regulatory and quality management, Manufacturing advanced therapies Not tracked yet
Target Customers
Patients with corneal endothelial diseases, Ophthalmologists, Healthcare providers specializing in vision care, Clinical researchers Not tracked yet
Taxonomy
Biotech, Clinical Stage, Advanced Therapies, Corneal Endothelial Disease, Cell Therapy, Biomedical, Ophthalmology, Clinical Trials, Regenerative Medicine, Innovation, Startup, Investing, Vision Care, Medical Research Regenerative Medicine, Cell Therapy, Corneal Blindness, Stem Cells, IPS-Derived Cells, Biomaterials, Tissue Regeneration, Cell Delivery, Off-the-Shelf Therapies
Website
aurionbiotech.com stemsight.fi
Aurion Biotech logo

About Aurion Biotech

Aurion Biotech, founded in 2022, is a promising clinical-stage biotech company, headquartered in the United States, with a clear mission embodied in its slogan: "We're on a mission to cure blindness with our transformational platform of advanced therapies." Specializing in biopharma and biotechnolo...

StemSight - Vision Unlimited logo

About StemSight - Vision Unlimited

StemSight is a biotechnology startup based in Finland, founded in 2021. The company's slogan, "Curing blindness with regenerative cell therapies," encapsulates its mission to develop off-the-shelf regenerative cell therapies for corneal blindness. StemSight's innovative approach involves the combina...

We will tell you when either one moves

BounceWatch watches Aurion Biotech and StemSight - Vision Unlimited for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Aurion Biotech and StemSight - Vision Unl... — by email.

Frequently Asked Questions

Aurion Biotech — We're on a mission to cure blindness with our transformational platform of advanced therapies. StemSight - Vision Unlimited — Curing blindness with regenerative cell therapies.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Aurion Biotech has raised $120.00M while StemSight - Vision Unlimited has raised $2.80M.
Aurion Biotech and StemSight - Vision Unlimited operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Aurion Biotech with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Aurion Biotech on 11 Sep 2024, and StemSight - Vision Unlimited on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy